NCT03553316View on ClinicalTrials.gov

Drug-Drug Interaction Between PK101-001 and PK101-002

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

March 22, 2019

Study Completion Date

April 24, 2019

Conditions
Arthritis
Interventions
DRUG

PK101-002

-(Single) PK101-002

COMBINATION_PRODUCT

PK101

-(Combination) PK101-001, PK101-002

Trial Locations (1)

Unknown

H Plus Yangji Clinical Research Center, Seoul

All Listed Sponsors
lead

PMG Pharm Co., Ltd

INDUSTRY

NCT03553316 - Drug-Drug Interaction Between PK101-001 and PK101-002 | Biotech Hunter | Biotech Hunter